UCLA study finds pre-surgery immunotherapy safe for pancreatic cancer patients
[ad_1] Findings A pilot study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that for people with borderline resectable pancreatic cancer, administrating an immunotherapy...